246 月6 月 24, 2026 MSC Therapy for Inflammatory Bowel Disease: Crohn’s and Ulcerative Colitis in 2026 MSC therapy is offering new hope for IBD patients who don’t respond to conventional biologics. Here’s what the 2026 clinical data shows. 间充质干细胞, 干细胞inflammatory bowel disease0 条评论 阅读更多...
Chinese 
English 
Russian 
French